Inside Wall Street: How Goldman Is Playing the Coming Tide of Generic Drugs
Generic drugs are expected to enjoy a banner year in 2011, prompting some investment pros to reformulate their portfolios to get a jump on the transition. For Goldman Sachs, that means betting on several wholesale distributors …